Print

Purpose

This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.

Condition

Eligibility

Eligible Ages
Over 18 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age 18 years and older - Patients that present for COVID-19 testing, have tested Covid negative, or Covid Positive patients.

Exclusion Criteria

  • Unable to consent - Patients on a ventilator - Pregnant Women

Study Design

Phase
Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Test group Participants who have a positive Covid-19 Test or negative Covid-19 test who provide a breath sample.
  • Diagnostic Test: Breath test
    Participants provide a breath sample

Recruiting Locations

More Details

NCT ID
NCT04760639
Status
Completed
Sponsor
Medical University of South Carolina

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.